WS Audiology A/S financials
WS Audiology A/S
549300FM1G5Q7DY0FQ65 | Line item | 2025 | 2024 | 2023 |
|---|---|---|---|
| Income statement | |||
| Revenue | €1.80B | €1.89B | — |
| Cost of sales | €684.0M | €1.14B | — |
| Gross profit | €1.12B | €755.0M | — |
| Operating profit (EBIT) | €129.0M | -€370.0M | — |
| Profit before tax | €578.0M | -€3.93B | — |
| Income tax expense | -€167.0M | -€218.0M | — |
| Profit for the year | €745.0M | -€3.71B | — |
| Total comprehensive income | €745.0M | -€3.71B | — |
| Cash flow statement | |||
| Cash generated from operations | €1.29B | €698.0M | — |
| Net cash from operating activities | €1.31B | €727.0M | — |
| Net cash from investing activities | -€727.0M | €6.31B | — |
| Net cash from financing activities | -€596.0M | -€7.01B | — |
| Dividends paid | €193.0M | €0 | — |
| Lease liability payments | €106.0M | €64.0M | — |
| Net change in cash | -€17.0M | €20.0M | — |
| Balance sheet | |||
| Total assets | €29.51B | €28.35B | €35.90B |
| Non-current assets | €27.49B | €26.10B | €33.85B |
| Property, plant & equipment | €211.0M | €232.0M | €219.0M |
| Right-of-use assets | €357.0M | €463.0M | €425.0M |
| Current assets | €2.02B | €2.26B | €2.04B |
| Inventories | €115.0M | €332.0M | €370.0M |
| Trade & other receivables | €72.0M | €117.0M | €95.0M |
| Cash & equivalents | €33.0M | €50.0M | €33.0M |
| Total equity | €4.51B | €2.24B | €4.77B |
| Non-current liabilities | €21.93B | €23.68B | €22.09B |
| Long-term borrowings | €21.07B | €0 | €0 |
| Lease liabilities (non-current) | €440.0M | €525.0M | €480.0M |
| Current liabilities | €3.07B | €2.44B | €9.04B |
| Lease liabilities (current) | €24.0M | €31.0M | €28.0M |
| Derived metrics | |||
| Operating margin | 7.2% | -19.5% | — |
| Net margin | 41.3% | -195.9% | — |
| Return on equity | 16.5% | -165.5% | — |
| Cash conversion ratio | 1.75× | -0.20× | — |
| Other reported items | |||
| Adjustments For Decrease Increase In Inventories | €217.0M | €38.0M | — |
| Adjustments For Decrease Increase In Other Assets | -€116.0M | €134.0M | — |
| Adjustments For Decrease Increase In Trade and Other Receivables | €1.26B | -€249.0M | — |
| Adjustments For Depreciation and Amortisation Expense and Impairment Loss Reversal of Impairment Loss Recognised In Profit Or Loss | €144.0M | €103.0M | — |
| Adjustments For Finance Income Cost | €616.0M | -€2.06B | — |
| Adjustments For Income Tax Expense | -€167.0M | -€218.0M | — |
| Adjustments For Increase Decrease In Other Liabilities | €340.0M | €314.0M | — |
| Adjustments For Increase Decrease In Trade and Other Payables | -€507.0M | €529.0M | — |
| Adjustments For Provisions | -€208.0M | €196.0M | — |
| Adjustments For Undistributed Profits of Associates | €1.0M | €3.0M | — |
| Cash Advances and Loans Made To Related Parties | €32.0M | €1.74B | — |
| Cash Flows From Used In Operations Before Changes In Working Capital | €311.0M | -€264.0M | — |
| Current Prepayments | €21.0M | €18.0M | €32.0M |
| Current Provisions | €0 | €92.0M | €12.0M |
| Current Tax Assets Current | €114.0M | €55.0M | €36.0M |
| Deferred Tax Assets | €586.0M | €491.0M | €321.0M |
| Effect of Exchange Rate Changes On Cash and Cash Equivalents | €0 | -€3.0M | — |
| Equity and Liabilities | €29.51B | €28.35B | €35.90B |
| Income Taxes Paid Refund Classified As Operating Activities | -€13.0M | -€29.0M | — |
| Increase Decrease Through Sharebased Payment Transactions | €37.0M | — | — |
| Increase Decrease Through Transactions With Owners | €1.68B | €1.18B | — |
| Intangible Assets Other Than Goodwill | €65.0M | €60.0M | €27.0M |
| Interest Expense | €2.08B | €2.09B | — |
| Interest Paid Classified As Financing Activities | €1.33B | €1.80B | — |
| Investments In Associates Accounted For Using Equity Method | €30.0M | €29.0M | €23.0M |
| Investments In Subsidiaries | €24.19B | €21.72B | €31.38B |
| Issued Capital | €30.0M | €30.0M | €30.0M |
| Noncurrent Prepayments | €7.0M | €9.0M | €12.0M |
| Noncurrent Provisions | €0 | €116.0M | €0 |
| Other Adjustments For Noncash Items | €38.0M | €3.0M | — |
| Other Comprehensive Income | €0 | €0 | — |
| Other Current Assets | €1.24B | €49.0M | €65.0M |
| Other Current Liabilities | €468.0M | €228.0M | €236.0M |
| Other Finance Income Cost | €1.95B | -€304.0M | — |
| Other Inflows Outflows of Cash Classified As Financing Activities | €21.07B | €0 | — |
| Other Noncurrent Assets | €2.05B | €3.09B | €1.45B |
| Other Noncurrent Liabilities | €422.0M | €322.0M | €0 |
| Other Operating Income Expense | €574.0M | €838.0M | — |
| Other Reserves | €37.0M | €0 | €0 |
| Proceeds From Issuing Shares | €1.68B | €0 | — |
| Research and Development Expense | €799.0M | €1.12B | — |
| Reserve of Exchange Differences On Translation | -€2.0M | -€2.0M | -€2.0M |
| Retained Earnings | €4.44B | €2.02B | €4.74B |
| Revenue From Interest | €747.0M | €338.0M | — |
| Selling General and Administrative Expense | €765.0M | €839.0M | — |
| Share of Profit Loss of Associates Accounted For Using Equity Method | €1.0M | €3.0M | — |
| Trade and Other Current Payables To Trade Suppliers | €102.0M | €199.0M | €269.0M |
Every line item above is a fact tagged in WS Audiology A/S's annual report
filed in the European Single Electronic Format (ESEF) under the IFRS
taxonomy (ifrs-full) — the income statement, balance sheet
and cash-flow statement as the filer reported them. Values are shown
as-is, in the reporting currency (EUR), without
rescaling; the row labels map to the underlying concept name (e.g.
Revenue → ifrs-full:Revenue, Operating profit →
ifrs-full:ProfitLossFromOperatingActivities, Diluted EPS →
ifrs-full:DilutedEarningsLossPerShare), and any concept
without a curated label is shown under “Other reported items” with its
de-camel-cased tag name. Only consolidated, default-member facts are
shown (segment / dimensional breakdowns are excluded).
“Derived metrics” (free cash flow, margins, ROE, …) are computed from those facts by the same model the U.S. financials pages use — not tagged by the filer.
Source: machine-readable OIM xBRL-JSON aggregated by filings.xbrl.org (XBRL International). Entity identity is resolved by LEI via the public-domain GLEIF register. This is reference data, not investment advice.